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This work proposes a novel approach for a suitable orientation of antibodies (Ab) on an immunosensing
platform, applied here to the determination of 8-hydroxy-2′-deoxyguanosine (8OHdG), a biomarker of
oxidative stress that has been associated to chronic diseases, such as cancer. The anti-8OHdG was bound
to an amine modiﬁed gold support through its Fc region after activation of its carboxylic functions. Non-
oriented approaches of Ab binding to the platform were tested in parallel, in order to show that the
presented methodology favored Ab/Ag afﬁnity and immunodetection of the antigen.
The immunosensor design was evaluated by quartz-crystal microbalance with dissipation, atomic
force microscopy, electrochemical impedance spectroscopy (EIS) and square-wave voltammetry. EIS was
also a suitable technique to follow the analytical behavior of the device against 8OHdG. The afﬁnity
binding between 8OHdG and the antibody immobilized in the gold modiﬁed platform increased the
charge transfer resistance across the electrochemical set-up. The observed behavior was linear from 0.02
to 7.0 ng/mL of 8OHdG concentrations. The interference from glucose, urea and creatinine was found
negligible. An attempt of application to synthetic samples was also successfully conducted.
Overall, the presented approach enabled the production of suitably oriented Abs over a gold platform
by means of a much simpler process than other oriented-Ab binding approaches described in the
literature, as far as we know, and was successful in terms of analytical features and sample application.
1. Introduction
Immunosensors combine an antibody as biological recognition
element with a transducer signaling device that follows the binding
of the free antigen (Ag) present in the solution under analysis and the
antibody (Ab) anchored to a solid support. The transducer converts
electrical, optical, mass or heat changes of the solution into a
measurable signal (Byrne et al., 2009; D'Orazio, 2003).
A critical step in immunosensor design is the immobilization of
the Ab on the solid support (Matharu et al., 2012). An Ab is a large
protein composed of hundreds of amino acids, arranged in a
tridimensional order that is recognized as a Y shape and where
the carboxyl (COOH) end of the peptide chain is positioned at
the lower end of this Y-shape structure. This region is also
recognized as Fc. Each Ab binds to a speciﬁc part of an Ag (epitope
region), through the two upper-end parts of this Y shape (paratope
region) that are amine-terminated. Each Ab is able to bind two Ag
species because there are two paratope sites in a single structure.
This is also feasible when the Ab is attached to solid-supports,
provided that the Ab is attached through the Fc region, therefore
leaving both paratope sites free for Ag binding.
Many approaches for immobilizing antibodies on a solid sup-
port lead to random orientation of these proteins all over the
modiﬁed surface, creating supports of low density binding sites
and of decreased binding afﬁnity (Song et al., 2012). These include
physical/electrostatic non-covalent adsorption or covalent cou-
pling via amine moieties, yielding surfaces highly covered by
antibodies with inactive orientation due to steric blocking of the
paratope sites (Alves et al., 2012). Despite resulting in a signiﬁcant
loss of Ab activity, these methods are still commonly used due to
their simplicity of execution.
Alternative strategies leading to suitable Ab orientation have
also been presented (Alves et al., 2012; Kausaite-Minkstimiene
et al., 2010; Song et al., 2012). The most common approach
includes attaching protein A or protein G to the biosensing surface
prior to Ab binding. These proteins bind speciﬁcally to the Fc
region of the antibodies, providing a suitable orientation of the
antibodies all over the surface. However, this additional step upon
the surface modiﬁcation decreases the ordered organization upon
the biosensing surface, simply because the proteins are also ran-
domly attached to the surface. Other approaches employ the reduc-
tion of disulﬁde bonds between the peptide chains present in the
same Ab, using the resulting thiol side chains as reactive sites
for conjugation to gold or maleimide functionalized surfaces
(Brogan et al., 2003; Lofas et al., 1995; Vikholm-Lundin, 2005).
This approach leads to many inactive Ab fragments where side-
disulﬁde bonds may be reduced accidently (Alves et al., 2012).
The orientation of these fragments upon the surface is also not
effective because in practice it becomes randomly bond to a gold
surface, yielding many non-speciﬁc regions for protein binding.
Other approaches include oxidizing carbohydrate chains that
are present on the antibodies, forming reactive aldehyde groups
that can bind amine functionalized surfaces (Han et al., 2010). This
technique provides a high coupling yield, but the denaturing condi-
tions and oxidative chemicals used can result in a signiﬁcant loss of
Ab activity. Overall, methods reporting oriented Ab binding involve
complex chemical procedures, requiring many stages of chemical
modiﬁcation that decrease the technical control over the nanostruc-
tures and some of these stages may also hinder Ab activity (Alves
et al., 2012). This stresses the need for the development of a simple
method for site oriented immobilization.
Thus, this work proposes a different and simpler immunosen-
sor design, by activating the carboxylic residues at the Fc site
(via carbodiimide reaction) and coupling these directly to an amine
functionalized surface. This carboxylic activation process has been
employed for decades for protein covalent binding and is expected
to be compatible with protein structures, therefore preventing
signiﬁcant loss of activity of Ab. In addition, although it may affect
all carboxylic functions in the outer layer of the protein structure,
there is a strong probability that most of the antibodies become
suitably oriented. Among the 20 amino acids in nature, only
aspartic and glutamic acids have carboxylic acid side chains, and
these would only be affected if exposed/directed to the outer
surface of the 3D structure of the protein.
This concept is here applied to an electrochemical impedance
spectroscopy (EIS) transduction, a direct and label-free method for
probing protein binding events such as those from Ab–Ag interac-
tions (Guan et al., 2001; Holford et al., 2012; Ronkainen et al., 2010).
It offers fast, accurate, sensitive, selective and quantitative responses,
coupled with portability, low cost and minimal power requirements.
EIS is also independent from sample turbidity or optical pathway,
widening the range of samples to which it may be applied.
As target analyte, a biomarker of oxidative stress will be
employed. Oxidative stress (OS) is the imbalance between oxidant-
producing systems and antioxidant defense mechanisms (such as, for
example, superoxide dismutase—SOD, and glutathione), resulting
in an excessive production of reactive oxygen species (Mancuso
et al., 2012; Ziech et al., 2010). This condition is widely recognized
as a central feature of many biological processes and diseases,
due to their impact on cell injury and death, being involved
in aging, neurodegenerative diseases, such as Alzheimer's disease,
Parkinson's disease, Huntington's disease, and cancer (Cui
et al., 2012; Repine et al., 1997; Zwart et al., 1999). Oxidative
adducts derived from DNA (Hwang, 2004), proteins, lipids, and
sugars, are widely used to measure OS levels in biological samples
(Ogino and Wang, 2007). This includes 8-hydroxy-2′-deoxygua-
nosine (8OHdG) which acts as an indicator of DNA oxidation
(Ogino and Wang, 2007; Valavanidis et al., 2009; Zwart et al.,
1999). Nowadays, the methods used to quantify this biomarker
involve complex, expensive and non-portable techniques (Fan
et al., 2012; Li et al., 2011; Wang et al., 2011; Zitka et al., 2011),
which impair a more effective utilization of OS biomarkers as a
predictive tool for degenerative disease installation. Only an
immunosensor is presented very recently in literature for 8OHdG,
but the overall procedure is very complex (Darwish et al., 2013).
Thus, this work describes a novel and simple approach for
designing an immunosensor presenting an Ab for 8OHdG (anti-
8OHdG) suitably oriented over a gold support, here tested for the
detection of 8OHdG, a cancer biomarker in urine related to nucleic
acid oxidation.
2. Experimental section
2.1. Apparatus
The electrochemical measurements were conducted with a
potentiostat/galvanostat from Metrohm Autolab, controlled by
NOVA 1.9 software. Atomic force microscopy measurements were
made in using tapping mode using a Veeco Metrology Multimode,
Nanoscope IVA. Quartz crystal microbalance (QCM) studies were
conducted in a QCM E4 from Q-sense, Biolin, with Dissipation
monitoring (QCM-D). A DXR™ Raman Microscope from Thermo
Scientiﬁc™ was used for Raman spectrometry with confocal
microscopy.
2.2. Gold supports
Electrochemical studies used Au-screen printed electrodes
(Au-SPEs) purchased from DropSens (DS-C223BT). These had work-
ing and counter electrodes of gold and reference electrode and
electrical contacts made of silver, interfaced in a switch box from
DropSens to enable its potentiostat/galvanostat reading. The gold
layer of the electrode was washed with alcohol (70%) and de-ionized
water before any use. All chemical modiﬁcations attempted with
these electrodes were made only by applying the reacting solution
solely on the working electrode.
AFM studies were conducted in Au-glass slides, where the Au
layer was deposited by sputtering to ensure its ﬂatness. This gold
layer was cleaned by gentile procedures before use, with Piranha
solution.
QCM-D studies were conducted with commercial chips from
Q-sense, Biolin. These had 14 mm diameter, 0.3 mm thickness quartz
glass with a ﬂat Au-layer on top and were cleaned with de-ionized
water before use.
2.3. Reagents and solutions
All chemicals were of analytical grade and water was de-
ionized or ultrapure Milli-Q laboratory grade. Potassium hexacya-
noferrate III (K3[Fe(CN)6]) and potassium hexacyanoferrate II
(K4[Fe(CN)6]) trihydrate were obtained from Riedel-deHaen; bovine
serum albumin (BSA), creatinine, urea, N-hydroxysuccinimide (NHS),
N-ethyl-N′-(3-dimethylaminopropyl) carbodiimide hydrochloride
(EDAC), 8-hydroxy-2-deoxyguanosine 98% (8OHdG), and 8-hydroxy-
guanosine, GTX (Ab-8OHdG) from Sigma; cysteamine and ethylene-
diamine from Merck; and dextrose anhydrous from Fisher.
Piranha solution was prepared by mixing in a cabinet H2SO4
and H2O2, in 5:1 ratio, using concentrated H2SO4 solution (95–97%,
Scharlau) and a 30% H2O2 (VWR). The Ab-8OHdG solution was
used after a 150 dilution of the commercial product. A 1 PBS
buffer, pH 7.3 (Amresco, E404, Biotechnology grade) was used
throughout this work. Synthetic urine was prepared as indicated
in Martinez et al., 2007.
2.4. Antibody immobilization
The reactions used for Ab immobilization are shown in Fig. 1.
A solution of cysteamine (50 mM) was placed on clean Au for 1 h.
Only the necessary volume to cover the working electrode area
was used, in order to prevent the solution from ﬂowing outside
the working area (Fig. S1). Before binding the newly formed
Au–NH2 layer, the Ab-8OHdG were modiﬁed by reaction with
NHS (50 mM) and EDAC (25 mM) prepared in buffer (MES, 50 mM,
pH 6), for 30 min. The modiﬁed Ab-8OHdG structures were added
after to the Au–NH2 layer for 1.5 h, at room temperature. Ethyle-
nediamine (20 mM, in PBS) was added next, for 2 h, to deactivate
the sites remaining active at the protein structure. BSA (0.5 mg/mL,
in PBS) was added later, for 1 h, at 4 1C, to block the non-speciﬁc
response of the Ab.
2.5. Antibody/antigen afﬁnity reaction
All procedures were made in triplicate. The time given for the
afﬁnity reaction between the Ab-8OHdG immobilized in the Au-
layer and the Ag (8OHdG, dispersed in the solution), was set to
15 min. The working 8OHdG solutions had varying concentrations
and were prepared in PBS buffer (pH 7.3) by accurate dilution of a
stock solution of 20 ng/mL.
2.6. Electrochemical experiments
EIS assays were conducted with a redox probe of [Fe(CN)6]3
(5.0 mM) and [Fe(CN)6]4 (5.0 mM), prepared in PBS buffer, pH
7.3, after Ab/Ag afﬁnity. This was done at a standard potential of
þ0.12 V, using a sinusoidal potential perturbation with amplitude
of 0.01 V and a number of frequencies equal to 50, logarithmically
distributed over a frequency range of 0.1–100 kHz. The recorded
EIS data was ﬁtted to a Randles equivalent circuit, using the Nova
Software from Autolab.
Selectivity studies were conducted by competitive assay between
8OHdG, with a 3 ng/mL concentration, and urea (0.5 mg/mL), crea-
tinine (0.012 mg/mL), and glucose (1.1 mg/mL), all solutions prepared
in PBS buffer, pH 7.3.
The calibration curves were made for 8OHdG concentrations
ranging from 0.02 to 7.0 ng/mL, and followed by both EIS and
square-wave voltammetry (SWV) measurements. SWV assays
were made by potential scanning from 0.2 toþ0.5 V, at 50 mV/s,
for a frequency of 50 Hz and a step height of 150 mV.
2.7. QCM-D experiments
QCM-D assays were made after stabilizing the baseline of a
cleaned gold chip with PBS carrier, pH 7.3, ﬂowing at 0.50 mL/min.
Once the equilibriumwas reached, the ﬂow was stopped to change
this solution by a solution of Ab-8OHG (1:10), prepared in the
same PBS buffer. Finally, and after reaching again the equilibrium,
the ﬂow was once more stopped to introduce a solution of 8OHG,
100 ng/mL.
3. Results and discussion
3.1. Antibody/antigen binding
The ability of the anti-8OHdG to bind to its target compound
when attached to a solid support of Au was checked by QCM-D
studies. Fig. 2 shows the diagrams obtained for frequency and
dissipation data versus time.
The Δf values decreased signiﬁcantly after injection of the Ab-
8OHdG, which conﬁrmed the physical adsorption of the Ab to the
Au layer. The saturation was almost reached at 20 min contact. The
observed increase in dissipation indicated that the formed ﬁlm
had viscoelastic properties, which is consistent with the random
adsorption of the Ab (of protein nature) on Au.
The Ag was then bound to its Ab layer, leading to a very small
increase in the observed frequency under equilibrium. This
increase is typically correlated to a mass decrease, which in a ﬁrst
approach seems inconsistent with the binding of 8OHdG to the Au/
Ab layer. However, the molar mass of the Ag (283.2 g/mol) is very
small compared to that of the Ab, meaning that this binding stage
would not generate a signiﬁcant mass increase. Since the observed
frequency increase is also linked to slight decrease in dissipation,
this behaviour may be attributed to the alteration of the protein (Ab)
conformation after 8OHdG binding, leading to the extraction of
hydration molecules over the Ab/Au layer and thus to a subsequent
mass loss.
Overall, QCM-D studies conﬁrmed that the Ab is able to bind its
Ag in PBS environment and when adsorbed to a solid support, and
that the layer of Ab has a non-rigid structure showing viscoelastic
properties.
Fig. 1. Design of the immunosensor. TOP: amine modiﬁcation of gold in parallel
with the activation of carboxylic functions of the Ab, and subsequent binding of
both materials in a single platform; right: binding the Ag 8OHdG to the Ab in the
platform, after blockage of the non-speciﬁc response (inset: EIS spectra of
Au/amine, Au/amine/Ab, Au/amine/Ab with ethylenediamine and Au/amine/Ab
with BSA).
Fig. 2. QCM-D records reporting measurements of frequency (blue, left Y axis) and
dissipation (red, right Y axis) against time for the different stages of the reaction
(as reported on top). (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
3.2. Immunosensor design
The two paratope sites in each immobilized Ab can bind Ag
molecules only if these regions can be easily accessed. For this
purpose, it is essential that each Ab bounded to the solid support
should be attached through its Fc region. Considering that this
region carries carboxylic functions, its activation via carbodiimide
reaction would allow its easy and mild covalent binding to an
amine layer.
So, the overall design of the immunosensor started by creating
an amine layer over the gold support (Fig. 1). This was done by
placing cysteamine on Au, a two carbon chain carrying an amine
group (NH2) in one end and a thiol function (SH) in the other
end. The contact between Au and SH leads to the spontaneous
formation of a strong Au-sulphur interaction, that is expected to
form a closely packed monolayer. In practice, the Au surface
becomes a stable amine layer (Au/amine), that was controlled by
EIS studies, presented in the inset of Fig. 1.
The carboxylic functions on the Ab were activated in parallel, in
order to enable its reaction with the amine layer under mild
conditions. This was done by the well know EDAC/NHS chemistry,
where the COOH group forms a highly reactive O-acylisourea
intermediate that reacts rapidly with NHS to produce a more
stable succinimydyl ester intermediate (Jiang et al., 2004). The
resulting ester undertakes easy nucleophilic substitution with the
amine groups on the Au/amine layer. The presence of Ab attached
to the amine layer (Au/amine/Ab) was conﬁrmed by a signiﬁcant
increase of the charge-transfer resistance (Rct) observed in the EIS
spectra. The Rct corresponds to the diameter of the semicircle and
measures directly the ability of the charge transfer to take place
between electrodes and surrounding electrolyte. Thus, the signiﬁ-
cant increase in the diameter of the semicircle (Fig. 1, inset)
showed an increased resistance in the electron transfer kinetics
of the redox-probe, accounting the formation of a resistive layer
due to the presence of protein material at the sensory surface.
Because this carboxylic activation occurring in the Ab material
was not carried out speciﬁcally at the COOH groups of the Fc
region, other carboxylic functions present on the outer surface of
the 3D structure of the Ab could undergo the same reaction and
become activated. In such condition, the target compound or other
amine-based compounds in a biological sample could bind to
these activated positions, contributing to decrease the selectivity
of the immunosensor. So, the carboxylic functions that remained
activated after Ab binding were inactivated by reaction with
ethylenediamine (inset in Fig. 1). This reagent is small in size,
having a two carbon chain with two end-amine functions, which is
expected to increase the effectiveness of the reaction and cause
little disturbance upon the 3D arrangement of the Ab.
Being the Ab a protein of enormous dimensions compared to its
target analyte, many of its surface area is able to interact with
other substances, especially those of protein nature. This is a
proprietary feature of any Ab that decreases the selectivity of
response in immunosensing. This has been solved in the literature
by adding a protein (different than the Ab or the Ag) of low
cost, typically BSA, in a high amount. The addition of BSA to the
immunosensor under development promoted a signiﬁcant increase
in the Rct value, as may be seen in the inset of Fig. 1. Again, this record
accounted the formation of a resistive barrier that caused a sig-
niﬁcant impedance increase, thus conﬁrming BSA binding to the
Au/amine/Ab surface.
3.3. AFM images
The AFM images of clean gold and Au/amine/Ab supports with
or without Ag may be seen in Fig. 3. The top image shows the
typical observation obtained with clean gold. The surface was not
exactly ﬂat because the gold support had been reused from a
previous experiment.
The presence of the anti-8OHdG on the Au/amine support was
evident from the signiﬁcant change observed in the surface
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Fig. 3. AFM images in 2D (left) and 3D (right) views of different materials: Au layer (top), Au/amine/Ab (middle) and Au/amine/Ab with antigen (bottom).
roughness (Fig. 3, middle). The observed surface was also quite
uniform, suggesting that most of the antibodies had a similar
orientation after binding, expectedly through the Fc region.
Finally, the addition of Ag also produced a small change in the
surface of the material (Fig. 3, bottom). This was more evident in
the 2D image. Considering the small size of the Ag, its binding to
the Au/amine/Ab support should not give rise to such a signiﬁcant
change at the obtained AFM image. However, this corroborates
well with the QCM-D data, regarding the conformational change in
the Ab after Ag binding.
3.4. Comparing to non-oriented design
In order to check if the modiﬁcation of the Fc region via
carboxylic activation was leading to an oriented binding of the
Ab and/or enhancing the analytical features of the biosensor, non-
oriented approaches were also established. Two different methods
were tested for this purpose: (i) non-speciﬁc adsorption of the Ab
to clean Au chips (Au/Ab-adsorbed); (ii) and non-speciﬁc adsorp-
tion of the Ab to the Au/amine layer (Au/amine/Ab-adsorbed).
The response of such immunosensors against 8OHdG is pre-
sented in Fig. 4, along with the response of the oriented approach
previously described. Overall, the binding events between 8OHdG
and anti-8OHdG in the immunosensor lead to an increase in
Rct. According to literature, it is common that the formation of
afﬁnity complexes leads to the formation of an insulating layer
that retards the interfacial electron transfer kinetics between the
redox probe and the electrode, thus increasing the electron-
transfer resistance (Ansari et al., 2010).
Comparing the immunosensors designed with oriented and
non-oriented approaches, it was clear that the non-controlled Ab
binding versions gave rise to devices with lower reproducibility,
because it was difﬁcult to ﬁnd repeated behaviour in devices
produced together. In addition, the spectra presented in Fig. 4
are clear with regard to the narrower and worse linear ranges
obtained with non-oriented designs. Immunosensors Au/Ab-adsorbed
displayed linear behaviour from 0.4 to 3.0 ng/mL, with a squared
correlation coefﬁcient of 0.955, and immunosensors of Au/amine/
Ab-adsorbed had linear behaviour from 0.020 to 3.0 ng/mL, with
a squared correlation coefﬁcient of 0.9405, and immunosensors
of Au/amine/Ab were linear all over the 8OHdG concentration
range tested.
3.5. Main analytical features
The calibration curves of the oriented immunosensors were
evaluated by both EIS and SWV studies, and the main analytical
features extracted from the average results of at least three
independent assays. The typical records are also shown in Fig. 5.
The EIS calibration was made by plotting Rct values of the EIS
spectra against 8OHdG concentration. A typical spectra is shown in
Fig. 5A, corresponding to Rct (Ω)¼685.23 [8OHdG, ng/mL]þ981.4,
Fig. 4. EIS spectra of immunosensors designed with non-oriented binding of antibodies (Au/Ab—adsorbed in the left and Au/amine/Ab—Adsorbed in the middle) and with
Ab covalently attached through the Fc activated region (Au/amine/Ab in the right), obtained for different 8OHdG standard concentrations.
A B
Fig. 5. Typical calibration proﬁle from: (A) EIS spectra (immunosensor with oriented antibody) and (B) SWV records, obtained against different 8OHdG standard
concentrations. Inset of (A) with the Randles circuit composed by the resistance of the solution phase, RS; the capacitance of the double layer, Cdl); the charge-transfer
resistance (Rct); and the Warburg diffusion element (W) from the bulk solution to the electrode interface.
with a squared correlation coefﬁcient of 0.9949. This behavior
included the concentration values tested, from 0.020 to 7.0 ng/mL,
but not all data points. This is however an occasional event as may
be seen from the typical calibration observed for other immuno-
sensor devices built-up in parallel (in Fig. S2). The regular 8OHdG
levels in urine lye within this range, meaning that the use of this
immunosensor may be extended to elevated levels of this cancer
biomarker in urine samples. A triplicate assay with different
devices showed that this extended linearity range was a repro-
ducible behavior. Squared correlation coefﬁcients were 40.991,
attributing also good linearity features to the observed response.
Absolute slope values were less reproducible from chip to chip
calibration. This variability was mostly attributed to variations in
the Ab solutions and in the working Au layer of each SPE chip,
used only in a single calibration and being disposed afterwards. In
practical terms, this slope variability within different units had no
effect on the immunosensor applicability, because the devices
were to be applied to samples by the standard addition method (as
direct calibration was unfeasible due to the irreversible response
of the device).
In SWV studies, the signal measured reﬂected the decreasing
ability of the platform to oxidize the iron species in þ2 oxidation
state, due to Ag binding and subsequent blocking of the electron-
transfer. In general, the blank signal was the highest value of
current obtained and this peak started decaying with the increas-
ing concentration of 8OHdG. The typical voltammograms so
obtained are presented in Fig. 5B. The calibration was expressed
as current (I, μA)¼0.2819 [8OHdG, ng/mL]þ2.9332, with a
squared correlation coefﬁcient of 0.9904, for concentrations
Z1.5 ng/mL (Fig. S2).
Comparing both electroanalytical approaches, EIS showed an
extended linear range against 8OHdG concentration, and was
therefore selected for further evaluation and possible application.
3.6. Antibody surface coverage
The area of the working electrode covered by Ab was calculated
by confocal microscopy coupled to Raman spectrometry. The
Raman spectra was recorded with a 532 nm laser, in the spectral
range of 200–3500 cm1, for 1 mW power and 2 exposures of
45 s, in combination with a 50 objective magniﬁcation for focus
and collection of Raman-scattered light. The confocal hole was set
to 25 μm.
The spectra of Au layer of the SPE had small Raman signal when
compared to that of the Au/amine/Ab. The image captured by the
video camera of Au/amine/Ab showed intense ﬂuorescence spots
that were more or less homogeneously distributed (Fig. S3A). Since
organic molecules swamp or obscure the background Raman
signal due their intrinsic ﬂuorescence, these spots seem to be
indicating the presence of the antibodies and their distribution
along the working support of the SPE. The mapping of the Raman
signals of Au/amine/Ab surface area may be seen in Fig. S3B. The
surface color in Fig. S3C indicated the distribution of Raman
intensities of the peak at 1935 cm1 Raman shift, a signal that
was never present in the Au blank layer. Accounting spectra with
Raman intensity over 90%, the Ab coverage was 86.7%, thus
conﬁrming the successful modiﬁcation of the Au-SPE with Ab.
3.7. Selectivity
The ability of the immunosensor to discriminate 8OHdG from
foreign species was tested by adding a ﬁxed concentration of 8OHdG
to the immunosensor, followed by the addition of an interfering
compound, present in concentrations that are expected to be equiva-
lent to those observed in normal physiological conditions. This study
was applied to glucose, urea and creatinine. In general, the observed
selectivity will depend mostly on the selectivity/speciﬁcity of the
Ab/Ag reaction and of the non-speciﬁc response presented by the
immunosensor platform.
The average Rct changes produced by the addition of glucose,
urea and creatinine were 8.373.1%, 8.671.5%, and 8.171.8%,
respectively. Overall, these values show small variability, attribut-
ing the devices a good reproducibility in % levels. The absolute
interference level was also low, suggesting that foreign species will
not play a signiﬁcant role at the response of the immunosensor.
3.8. Application to urine analysis
Because Ab/Ag binding is irreversible, urine samples had to be
analyzed by the standard addition method. For this purpose, blank
synthetic urine samples with a background level of 8OHdG equal
to 1.50 ng/mL were incubated in the sensor. This concentration
level is below the normal physiological levels expected for this
oxidized metabolite. After this, consecutive additions of standards
were made, ranging from 3.0 to 7.0 ng/mL (the concentration
range used for the normal calibration). The sample concentration
was calculated after subtracting the blank signal to all standards,
plotting the so obtained Rct data and calculating the X intercept for
Y¼0. The concentration level obtained was 1.59 ng/mL, corre-
sponding to a relative error of 5.8%. This result suggested that the
developed immunosensor is leading to accurate data. Its simplicity
of design suggests the possibility of using it in routine procedures,
once the values are validated against real samples.
4. Conclusions
A simple Ab binding procedure is presented, with all stages of
analytical modiﬁcation, including analyte binding, being evaluated
by several techniques. Ag binding to the immobilized Ab seems to
produce conformation changes in the antibody and affects the
charge resistance transfer over the immunosensing platform for a
standard redox probe; additional studies are required to conclude
such conformational alterations. The successful analytical features
presented by EIS studies suggest that a suitable orientation of the
Ab over a gold-modiﬁed platform was successfully achieved.
Overall, the immunosensor described here is simple, and may
allow routine use of other immunosensor devices on-site, offering
lower linear response ranges for the 8OHdG than the most
sensitive commercial kits available. The time and efforts required
for the devices setup are signiﬁcantly reduced, allowing it to be
disposed off afterwards without signiﬁcant costs.
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